MedPath

FARMINTERPRAISEZ, OOO

🇷🇺Russia
Ownership
-
Employees
-
Market Cap
-
Website

XC8 Safety, Tolerability and Pharmacokinetics in Healthy Volunteers

Phase 1
Completed
Conditions
Asthma
Interventions
Drug: Placebo
First Posted Date
2018-02-22
Last Posted Date
2018-02-22
Lead Sponsor
PHARMENTERPRISES LLC
Target Recruit Count
28
Registration Number
NCT03441815
Locations
🇷🇺

SBEI HPE The First Moscow State Medical University n.a. Sechenov of Ministry of Health of Russian Federation, University Hospital #2, Department of Development of New Medicines, Moscow, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath